RCEL
AVITA Medical, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$11.02
−1.78%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.24
- Revenue estimate
- $22.6M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.25
- EPS estimate
- -$0.29
- Revenue actual
- $21.5M
- Revenue estimate
- $20.1M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +24.8%
- Revenue beats (12Q)
- 4
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $12
- PT range
- $11 – $14
- Analysts
- 4
4 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.29 | -$0.25 | Beat 14.62% | $21.5M |
| May 14, 2026 | -$0.35 | -$0.35 | In line | $19.3M |
| Feb 12, 2026 | -$0.48 | -$0.04 | Beat 91.37% | $17.6M |
| Nov 6, 2025 | -$0.43 | -$0.46 | Miss -6.98% | $17.1M |
| Aug 7, 2025 | -$0.26 | -$0.38 | Miss -46.15% | $12.0M |
| May 8, 2025 | -$0.39 | -$0.53 | Miss -35.90% | $11.6M |
| Feb 13, 2025 | -$0.30 | -$0.44 | Miss -46.67% | $11.4M |
| Nov 7, 2024 | -$0.42 | -$0.62 | Miss -47.62% | $13.5M |
| Aug 8, 2024 | -$0.59 | -$0.60 | Miss -1.69% | $10.1M |
| Feb 22, 2024 | -$0.34 | -$0.28 | Beat 17.65% | $9.7M |
| Nov 9, 2023 | -$0.53 | -$0.34 | Beat 35.85% | $13.6M |
| Aug 10, 2023 | -$0.34 | -$0.41 | Miss -20.59% | $11.7M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026